Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial

Surgery for Obesity and Related Diseases

Volumn 14, Issue 10, 2018, Pages 1504-1512

  Yang, Jingge ^a   Gao, Zhiguang ^b   Williams, D Brandon ^c   Wang, Cunchuan ^a   Lee, Shing ^a   Zhou, Xiangmao ^a   Qiu, Peicai ^b  

^a THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^b Dongguan 3rd People's Hospital   (China)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Gastrointestinal hormones; Pancreatic peptide hormones; Roux en Y gastric bypass; Sleeve gastrectomy

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; INSULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; BIOLOGICAL MARKER; GASTROINTESTINAL HORMONE; PANCREAS HORMONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FASTING; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; MALE; MEASUREMENT; OBESE PATIENT; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROUX-EN-Y GASTRIC BYPASS; SURGICAL TECHNIQUE; BARIATRIC SURGERY; BLOOD; BODY WEIGHT LOSS; CLINICAL TRIAL; DIET RESTRICTION; GASTRECTOMY; GASTRIC BYPASS SURGERY; LAPAROSCOPY; METABOLISM; MORBID OBESITY; PHYSIOLOGY; PROCEDURES;

ADULT; BARIATRIC SURGERY; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GASTROINTESTINAL HORMONES; GLUCAGON; HUMANS; INSULIN; LAPAROSCOPY; MALE; OBESITY, MORBID; PANCREATIC HORMONES; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 85052507995     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2018.06.003     Document Type: Article

References (41)

1. Cesare, MD, Bentham, J, Stevens, GA, et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387:10026 (2016), 1377–1396.
2. Sala, PC, Torrinhas, RS, Giannellaneto, D, et al. Relationship between gut hormones and glucose homeostasis after bariatric surgery. Diabetol Metabol Syndr 6:1 (2014), 1–12.
3. Dicker, D, Yahalom, R, Comaneshter, DS, et al. Long-term outcomes of three types of bariatric surgery on obesity and type 2 diabetes control and remission. Obes Surg 26:8 (2016), 1814–1820.
4. Santry, HP, Gillen, DL, Lauderdale, DS, Trends in bariatric surgical procedures. JAMA 294:15 (2005), 1909–1917.
5. Smith, BR, Schauer, P, Nguyen, NT, Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinol Metab Clin North Am 37:4 (2008), 943–964.
6. Juodeikis, Ž Brimas, G, Long-term results after sleeve gastrectomy: a systematic review. Surg Obes Relat Dis 13:4 (2017), 693–699.
7. Ramón, JM, Salvans, S, Crous, X, et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg 16:6 (2012), 1116–1122.
8. Peterli, R, Wölnerhanssen, B, Peters, T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:2 (2009), 234–241.
9. Nosso, G, Griffo, E, Cotugno, M, et al. Comparative effects of Roux-en-Y gastric bypass and sleeve gastrectomy on glucose homeostasis and incretin hormones in obese type 2 diabetic patients: a one-year prospective study. Horm Metab Res 48:5 (2016), 312–317.
10. Jacobsen, SH, Dirksen, C, Jørgensen, NB, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 22:7 (2012), 1084–1096.
11. Romero, F, Nicolau, J, Flores, L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc 26:8 (2012), 2231–2239.
12. Umeda, LM, Silva, EA, Carneiro, G, et al. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients. Obes Surg 21:7 (2011), 896–901.
13. Malin, SK, Kashyap, SR, Differences in weight loss and gut hormones: Rou-en-Y gastric bypass and sleeve gastrectomy surgery. Curr Obes Rep 4:2 (2015), 279–286.
14. Meek, CL, Lewis, HB, Reimann, F, et al. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides 77 (2015), 28–37.
15. Beckman, LM, Beckman, TR, Sibley, SD, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enternal Nutr 35:2 (2011), 169–180.
16. Farey, JE, Preda, TC, Fisher, OM, et al. Effect of laparoscopic sleeve gastrectomy on fasting gastrointestinal, pancreatic, and adipose-derived hormones and on non-esterified fatty acids. Obes Surg 27:2 (2017), 399–407.
17. Batterham, RL, Heffron, H, Kapoor, S, et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metabol 4:3 (2006), 223–233.
18. Karamanakos, SN, Vagenas, K, Kalfarentzos, F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial Ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247:3 (2008), 401–407.
19. Alamuddin, N, Vetter, ML, Ahima, RS, et al. Changes in fasting and prandial gut and adiposity hormones following vertical sleeve gastrectomy or Roux-en-Y-gastric bypass: an 18-month prospective study. Obes Surg 27:6 (2017), 1563–1572.
20. Chandarana, K, Gelegen, C, Karra, E, et al. Diet and gastrointestinal bypass-induced weight loss: the roles of Ghrelin and peptide YY. Diabetes 60:3 (2011), 810–818.
21. Date, Y, Kojima, M, Hosoda, H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:11 (2000), 4255–4261.
22. Tong, J, Prigeon, RL, Davis, HW, et al. Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans. Diabetes 59:9 (2010), 2145–2151.
23. Malin S, K, Samat, A, Wolski, K, et al. Improved acylated Ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Int J Obes 38:3 (2013), 364–370.
24. Martins, C, Kjelstrup, L, Mostad, IL, et al. Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on Ghrelin, obestatin, and Ghrelin/obestatin ratio in morbidly obese patients. Obesity Surgery 21:6 (2011), 751–758.
25. Chambers, AP, Kirchner, H, Wilson-Perez, HE, et al. The effects of vertical sleeve gastrectomy in rodents are Ghrelin independent. Gastroenterology 144:1 (2013), 50–52 e55.
26. Meier, JJ, Gallwitz, B, Salmen, S, et al. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:6 (2003), 2719–2725.
27. Gallwitz, B., Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 23:1 (2016), 23–27.
28. Le, RC, Borg, CK, Vincent, RP, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg 252:1 (2010), 50–56.
29. Ionut, V, Burch, M, Youdim, A, et al. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity 21:6 (2013), 1093–1103.
30. Ye, J, Hao, Z, Mumphrey, MB, et al. GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Comp Physiol 306:5 (2014), R352–R362.
31. Wilsonpérez, HE, Chambers, AP, Ryan, KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency. Diabetes 62:7 (2013), 2380–2385.
32. Rao, RS, Kini, S, GIP and bariatric surgery. Obes Surg 21:2 (2011), 244–252.
33. Miyawaki, K, Yamada, Y, Ban, N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:7 (2002), 738–742.
34. Falkén, Y, Hellström, PM, Holst, JJ, et al. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metabol 96:7 (2011), 2227–2235.
35. Korner, J, Bessler, M, Inabnet, W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 3:6 (2007), 597–601.
36. Batterham, RL, Cummings, DE, Mechanisms of diabetes improvement following bariatric/metabolic surgery. Diabetes Care 39:6 (2016), 893–901.
37. Shukla, A, Rubino, F, Secretion and function of gastrointestinal hormones after bariatric surgery: their role in type 2 diabetes. Can J Diabetes 35:2 (2011), 115–122.
38. Thomas, F, Smith, GC, Lu, J, et al. Differential acute impacts of sleeve gastrectomy, Roux-en-Y gastric bypass surgery and matched caloric restriction diet on insulin secretion, insulin effectiveness and non-esterified fatty acid levels among patients with type 2 diabetes. Obes Surg 26:8 (2016), 1924–1931.
39. Shoar, S, Saber, AA, Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis 13:2 (2016), 170–180.
40. Swarbrick, MM, Stanhope, KL, Austrheim-Smith, IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 51:10 (2008), 1901–1911.
41. Nannipieri, M, Baldi, S, Mari, A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metabol 98:11 (2013), 4391–4399.